Involvement of cytokines in normal CNS development and neurological diseases: Recent progress and perspectives

Journal of Neuroscience Research

Volumn 52, Issue 1, 1998, Pages 7-16

  Zhao, Boyu ^a   Schwartz, Joan P ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Alzheimer's disease; Inflammation; Multiple sclerosis; Stroke; Transgenic mice

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 3; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; CYTOKINE PRODUCTION; MULTIPLE SCLEROSIS; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NEUROBIOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOSIS; SECOND MESSENGER; SHORT SURVEY; SIGNAL TRANSDUCTION; STROKE;

ANIMALS; BRAIN; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; MENTAL DISORDERS; MICE; MULTIPLE SCLEROSIS; NERVE DEGENERATION;

EID: 0032053686     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980401)52:1<7::AID-JNR2>3.0.CO;2-I     Document Type: Short Survey

References (129)

1. Akiyama H (1997): Alzheimer's disease and microglia. Dementia 11:378-387.
2. Andersen K, Launer LJ, Ott A, Hoes AW, Breteln MM, Hofman A (1995): Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam study. Neurology 45:1441-1445.
3. Araujo DM, Cotman CW (1993): Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: Potential involvement of glial-derived factors. Brain Res 600:49-55.
4. Araujo DM, Lapchak PA (1994): Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: Selective effects on specific interleukins and interleukin receptors. Neurosci 61:745-754.
5. Arvin B, Neville LF, Barone FC, Feuerstein GZ (1996): The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev 20:445-452.
6. Baker I, Masserano J, Wyatt RJ (1996): Serum cytokine concentrations in patients with schizophrenia. Schizophr Res 20:199-203.
7. Ban EM, Sarlieve LL, Haour FG (1993): Interleukin-1 binding sites on astrocytes. Neuroscience 52:725-733.
8. Barger SW, Harmon AD (1997): Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388:878-881.
9. Barger SW, Mattson MP (1997): Isoform-specific modulation by apolipoprotein E of the activities of secreted β-amyloid precursor protein. J Neurochem 69:60-67.
10. Barone FC, Hillegass LM, Tzimas MN, Schmidt DB, Foley J, White RF, Price W, Feuerstein GZ, Clark RK, Griswold DE (1995): Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal stroke. Mol Chem Neuropath 24:13-30.
11. Barone FC, Arvin B, White RF, Miller A, Webb CR, Willette RN, Lysko PG, Feuerstein GZ (1997): Tumor necrosis factor-α: A mediator of focal ischemic brain injury. Stroke 28:1233-1244.
12. Bartfai T, Schultzberg M (1993): Cytokines in neuronal cell types. Neurochem Int 22:435-444.
13. Bellinger FP, Madamba S, Siggins GR (1993): Interleukin 1-β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res 628:227-234.
14. Bellinger FP, Madamba SG, Campbell IL, Siggins GR (1995): Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6. Neurosci Lett 198:95-98.
15. Benveniste EN (1992): Inflammatory cytokines within the central nervous system: Sources, function, and mechanism of action. Am J Physiol 263:C1-C16.
16. Blum-Degen D, Muller T, Kuhn W, Gerlach M, Przuntek H, Riederer P (1995): Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett 202:17-20.
17. Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, Copeland NG, Price DL, Sisodia SS (1997): Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19:939-945.
18. Böttinger EP, Letterio JJ, Roberts AB (1997): Biology of TGF-β in knockout and transgenic mouse models. Kidney Int 51:1355-1360.
19. Breder CD, Dinarello CA, Saper CB (1988): Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 240:321-324.
20. Breitner JCS (1996): The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu Rev Med 47:401-411.
21. Brenneman DE, Schultzberg M, Bartfai T, Gozes I (1992): Cytokine regulation of neuronal survival. J Neurochem 58:454-460.
22. Brett FM, Mizisin AP, Powell HC, Campbell IL (1995): Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol 54:766-775.
23. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MBA, Mucke L (1993): Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 90:10061-10065.
24. Campbell IL, Hobbs MV, Kemper P, Oldstone MBA (1994): Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis. J Immunol 152:716-723.
25. Chiang C-S, Stalder A, Samimi A, Campbell IL (1994): Reactive gliosis as a consequence of interleukin-6 expression in the brain: Studies in transgenic mice. Dev Neurosci 16:212-221.
26. Chiang C-S, Powell HC, Gold LH, Samimi A, Campbell IL (1996): Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J Clinn Invest 97:1512-1524.
27. Christopher TA, Lopez BL, Yue TL, Feuerstein GZ, Ruffolo RR, Ma XL (1995): Carvediol, a new beta-adrenoreceptor blocker, vasodilator and free-radical scavenger, exerts an anti-shock and endothelial protective effect in rat splanchnic ischemia and reperfusion. J Pharmacol Exp Ther 273:64-71.
28. Cockayne DA, Bodine DM, Cline A, Nienhuis AW, Dunbar CE (1994): Transgenic mice expressing antisense interleukin-3 RNA develop a B-cell lymphoproliferative syndrome or neurologic dysfunction. Blood 84:2699-2710.
29. Cooper AL, Brouwer S, Turnbull AV, Luheshi GN, Hopkins S, Kunkel SL, Rothwell NJ (1994): Tumor necrosis factor-α and fever after peripheral inflammation in the rat. Am J Physiol 267: R1431-R1436.
30. Cotman C, Tenner AJ, Cummings BJ (1996): Beta-amyloid converts an acute phase injury response to chronic injury responses. Neurobiol Aging 17:723-731.
31. deKloet ER, Oitzl MS, Schobitz B (1994): Cytokines and the brain corticosteroid receptor balance: Relevance to pathophysiology of neuroendocrine-immune communication. Psychoneuroendocrinology 19:121-134.
32. Eddleston M, Mucke L (1993): Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience 54:15-36.
33. el-Mallakh R, Suddath R, Wyatt RJ (1993): Interleukin-1α and interleukin-2 in cerebrospinal fluid of schizophrenic subjects. Prog Neuropsychopharmacol Biol Psychiatry 17:383-391.
34. Eng LF, Ghirnikar RS, Lee YL (1996): Inflammation in EAE: Role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem Res 21:511-525.
35. Erkman L, Wuarin L, Cadelli D, Kato A (1989): Interferon induces astrocyte maturation causing an increase in cholinergic properties of cultured human spinal cord cells. Dev Biol 132:375-388.
36. Farrar WL, Kilian PL, Ruff MR, Hill JM, Pert CB (1987): Visualization and characterization of interleukin 1 receptors in brain. J Immunol 139:459-463.
37. Fattori E, Lazzaro D, Musiani P, Modesti A, Alonzi T, Ciliberto G (1995): IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur J Neurosci 7:2441-2449.
38. Finch CE, Laping NJ, Morgan TE, Nichols NR, Painetti GM (1993): TGF-β1 is an organizer of responses to neurodegeneration. J Cell Biochem 53:314-322.
39. Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A (1989): On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur J Immunol 19:689-694.
40. Gadient RA, Otten U (1993): Differential expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat hypothalamus. Neurosci Lett 153:13-16.
41. Gadient R, Otten U (1994): Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res 637:10-14.
42. Galbreath E, Kim SJ, Park K, Brenner M, Messing A (1995): Overexpression of TGF-β1 in the central nervous system of transgenic mice results in hydrocephalus. J Neuropathol Exp Neurol 54:339-349.
43. Gallicchio VS, Chen MG, Watts TD (1984): Specificity of lithium (Li+) to enhance the production of colony stimulating factor (GM-CSF) from mitogen-stimulated lymphocytes in vitro. Cell Immunol 85:58-66.
44. Giulian D, Young DG, Woodward J, Brown DC, Lachman LB (1988a): Interleukin-1 is an astroglial growth factor in the developing brain. J Neurosci 8:709-714.
45. Giulian D, Vaca K, Johnson B (1988b): Secreted peptides as regulators of neuron-glia and glia-glia interactions in the developing nervous system. J Neurosci Res 21:487-500.
46. Giulian D, Chen J, Ingeman JE, George J, Noponen M (1989): The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci 9:4416-4429.
47. Giulian D, Corpuz M, Chapman S, Mansouri M, Robertson C (1993): Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system. J Neurosci Res 36:681-693.
48. Glabinski AR, Tani M, Aras S, Stoler MH, Tuohy VK, Ransohoff RM (1995): Regulation and function of central nervous system chemokines. Int J Dev Neurosci 13:153-165.
49. Hallenbeck JM (1996): Inflammatory reactions at the blood-endothelial interface in acute stroke. Adv Neurol 71:281-300.
50. Hama T, Kushima Y, Miyamoto M, Kubota M, Takei N, Hatanaka H (1991): Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience 40:445-452.
51. Hardy J (1997): Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 20:154-159.
52. Hermans G, Stinissen P, Hauben L, Van den Berg-Loonen E, Raus J, Zheng JT (1997): Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals. Ann Neurol 42:18-27.
53. Heyser CJ, Masliah E, Samimi A, Campbell IL, Gold LH (1997): Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci USA 94:1500-1505.
54. Hickie I, Lloyd A (1995): Are cytokines associated with neuropsychiatrie syndromes in humans? Int J Immunopharmacol 17:677-683.
55. Huell M, Strauss S, Volk B, Berger M, Bauer J (1995): Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathol 89:544-551.
56. Improta T, Salvatore AM, DiLuzio A, Romeo G, Coccia EM, Calissano P (1988): IFN-gamma facilitates NGF-induced neuronal differentiation in PC12 cells. Exp Cell Res 179:1-9.
57. Johansson A, Olsson T, Carlberg B, Karlsson K, Fagerlund M (1997): Hypercortisolism after stroke-partly cytokine-mediated? J Neurol Sci 147:43-47.
58. Jonakait GM, Wei R, Sheng Z-L, Hart RP, Li N (1994): Interferon-gamma promotes cholinergic differentiation of embryonic septal nuclei and adjacent basal forebrain. Neuron 12:1149-1159.
59. Jonakait GM, Luskin MB, Wei R, Tian X-F, Ni L (1996): Conditioned medium from activated microglia promotes cholinergic differentiation in the basal forebrain in vitro. Dev Biol 177:85-95.
60. Kamegai M, Niijima K, Kunishita T, Nishizawa M, Ogawaa M, Araki M, Ueki A, Konishi Y, Tabira T (1990): Interleukin 3 as a trophic factor for central cholinergic neurons in vitro and in vivo. Neuron 4:429-436.
61. Katila H, Appelberg B, Hurme M, Rimón R (1994): Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders. Schizophr Res 12:29-34.
62. Katsuki H, Nakai S, Hirai Y, Akaji K, Kiso Y, Satoh M (1990): Interleukin-1β inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur J Pharmacol 181:323-326.
63. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, Kollias G (1991): Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis. EMBO J 10:4025-4031.
64. Kim JS, Yoon SS, Kim YH, Ryu JS (1996): Serial measurement of interleukin-6, transforming growth factor-β, and S-100 protein in patients with acute stroke. Stroke 27:1553-1557.
65. Klir J, McClellan JL, Kluger MJ (1994): Interleukin-1β causes the increase in anterior hypothalamic interleukin-6 during LPS-induced fever in rats. Am J Physiol 266:R1845-R1848.
66. Kushima Y, Hatanaka H (1992a): Interleukin-6 and leukemia inhibitory factor promote the survival of acetylcholinesterase-positive neurons in culture from embryonic rat spinal cord. Neurosci Lett 143:110-114.
67. Kushima Y, Hama T, Hatanaka H (1992b): Interleukin-6 as a neurotrophic factor for promoting the survival of cultured catecholaminergic neurons in a chemically defined medium from fetal and postnatal rat midbrains. Neurosci Res (Shannon, Irel.), 13(4):267-280.
68. Laye S, Parnet P, Goujon E, Dantzer R (1994): Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Mol Brain Res 27:157-162.
69. Lechan RM, Toni R, Clark BD, Cannon JG, Shaw AR, Dinarello CA, Reichlin S (1990): Immunoreactive interleukin-1β localization in the rat forebrain. Brain Res 514:135-140.
70. Lin MT, Rao TY, Jin YT, Chen CF (1995): Interleukin-1 receptor antagonist attenuates the heat stroke-induced neuronal damage by reducing the cerebral ischemia in rats. Brain Res Bull 37:595-598.
71. Lindholm D, Heumann R, Hengerer B, Thoenen H (1988): Interleukin 1 increases stability and transcription of mRNA encoding nerve growth factor in cultured rat fibroblasts. J Biol Chem 263:16348-16351.
72. Lindholm D, Heumann R, Meyer M, Thoenen H (1987): Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 330:658-659.
73. Liu T, Young PR, McDonnell PC, White RF, Barone FC, Feuerstein GZ (1993): Cytokine-induced neutrophil chemoattractant mRNA expressed in cerebral ischemia. Neurosci Lett 164:125-128.
74. Long NC, Morimoto A, Nakamori T, Murakami N (1992): Systemic injection of TNF-α attenuates fever due to IL-Iα and LPS in rats. Am J Physiol 263:R987-R991.
75. Maimone D, Guazzi GC, Annunziata P (1997): IL-6 detection in multiple sclerosis brain. J Neurol Sci 146:59-65.
76. Malek-Ahmadi P (1996): Neuropsychiatric aspects of cytokine research: An overview. Neurosci Biobehav Rev 20:359-365.
77. Mannie MD, Dinarello CA, Paterson PY (1987): Interleukin 1 and myelin basic protein synergistically augment adoptive transfer activity of lymphocytes mediating experimental autoimmune encephalomyelitis in Lewis rats. J Immunol 138:4229-4235.
78. Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, Jungbluth A, Wada H, Moore M, Williamson B, Basu S, Old LJ (1997): Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 94:8093-8098.
79. Mattson MP, Rydel RE, Lieberburg I, Smith-Swintosky VL (1993): Altered calcium signaling and neuronal injury: Stroke and Alzheimer's disease as examples. Ann NY Acad Sci 679:1-21.
80. McAllister CG, van Kammen DP, Rehn TJ, Miller AC, Gurklis J, Kelley ME, Ydo J, Peters JL (1995): Increases in CSF levels of interleukin-2 in schizophrenia: Effects of recurrence of psychosis and medication status. Am J Psychiatry 152:1291-1297.
81. McGeer PL, McGeer EG (1995): Chronic inflammatory mechanisms of the brain. Implications for the treatment of Alzheimer's disease. Dementia 9:111-123.
82. McRae A, Dahlstroem A, Ling EA (1997): Microglia in neurodegenerative disorders. Emphasis on Alzheimer's disease. Gerontology 43:95-108.
83. Merrill JE, Jonakait GM (1995): Interactions of the nervous and immune systems in development, normal brain homeostasis, and disease. FASEB J 9:611-618.
84. Miller LG, Galpern WR, Dunlap K, Dinarello CA, Turner TJ (1991): Interleukin-1 augments γ-aminobutyric acidA receptor function in brain. Mol Pharmacol 39:105-108.
85. Mitrovic B, Ignarro LJ, Vinters HV, Akers MA, Schmid I, Uittenbogaart C, Merrill J (1995): Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience 65:531-539.
86. Mittleman BB, Castellanos FX, Jacobsen LK, Rapoport JL, Swedo SE, Shearer GM (1997): Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J Immunol 159:2994-2999.
87. Mosmann TR, Sad S (1996): The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146.
88. Mrak RE, Griffin WST (1997): The role of chronic self-propagating glial responses in neurodegeneration: Implications for long-lived survivors of human immunodeficiency virus. J Neuro Virol 3:241-246.
89. Nakafuku M, Satoh T, Kaziro Y (1992): Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6, induce an accumulation of an active Ras.GTP complex in rat pheochromocytoma PC12 cells. J Biol Chem 267:19448-19454.
90. Navikas V, Link H (1996): Cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 45:322-333.
91. Norris JG, Benveniste EN (1993): Interleukin-6 production by astrocytes: Induction by the neurotransmitter norepinephrine. J Neuroimmunol 45:137-145.
92. Norris JG, Tang LP, Sparacio SM, Benveniste EN (1994): Signal transduction pathways mediating astrocyte IL-6 induction by IL-1β and tumor necrosis factor-α. J Immunol 152:841-850.
93. Olsson T (1995): Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev 144:245-268.
94. Patterson PH (1994): Leukemia inhibitory factor, a cytokine at the interface between neurobiology and immunology. Proc Natl Acad Sci USA 91:7833-7835.
95. Patterson PH (1995): Cytokines in Alzheimer's disease and multiple sclerosis. Curr Opin Neurobiol 5:642-646.
96. Patterson PH, Nawa H (1993): Neuronal differentiation factors/ cytokines and synaptic plasticity. Cell 72:123-137.
97. Plata-Salaman CR, Ffrench-Mullen JMH (1994): Interleukin-1β inhibits Ca2+ channel currents in hippocampal neurons through protein kinase C. Eur J Pharmacol 266:1-10.
98. Pousset F (1994): Developmental expression of cytokine genes in the cortex and hippocampus of the rat central nervous system. Dev Brain Res 81:143-146.
99. Probert L, Akassoglou K, Kassiotis G, Pasparakis M, Alexopoulou L, Kollias G (1997): TNF-α transgenic and knockout models of CNS inflammation and degeneration. J Neuroimmunol 72:137-141.
100. Righi M, Mori L, DeLibero G, Sironi M, Biondi A, Mantovani A, Donini SD, Ricciardi-Castagnoli P (1989): Monokine production by microglial cell clones. Eur J Immunol 19:1443-1448.
101. Ringheim GE, Burgher KL, Heroux JA (1995): Interleukin-6 mRNA expression by cortical neurons in culture: Evidence for neuronal sources of interleukin-6 production in the brain. J Neuroimmunol 63:113-123.
102. Robbins DS, Shirazi Y, Drysdale B-E, Lieberman A, Shin HS, Shin ML (1987): Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 139:2593-2597.
103. Romagnani S (1994): Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:227-257.
104. Rothwell NJ (1997): Neuroimmune interactions: The role of cytokines. Br J Pharmacol 121:841-847.
105. Rothwell NJ, Relton JK (1993): Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci Biobehav Rev 17:217-227.
106. Rothwell NJ, Luheshi G, Toulmond S (1996): Cytokines and their receptors in the central nervous system: Physiology, pharmacology, and pathology. Pharmacol Ther 69:85-95.
107. Sasaki A, Yamaguchi H, Ogawa A, Suzihara S, Nakazoto Y (1997): Microglial activation in early stages of amyloid β protein deposition. Acta Neuropathol 94:316-322.
108. Sawada M, Suzumura A, Marunouchi T (1992): TNF-α induces IL-6 production by astrocytes but not by microglia. Brain Res 583:296-299.
109. Sawada M, Itoh Y, Suzumura A, Marunouchi T (1993): Expression of cytokine receptors in cultured neuronal and glial cells. Neurosci Lett 160:131-134.
110. Sébire G, Emilie D, Wallon C, Héry C, Devergne O, Delfraissy JF, Galanaud P, Tardieu M (1993): In vitro production of IL-6, IL-1β, and tumor necrosis factor-α by human embryonic microglial and neural cells. J Immunol 150:1517-1523.
111. Selkoe DJ (1997): Alzheimer's disease: Genotypes, phenotypes, and treatments. Science 275:630-631.
112. Shalit F, Sredni B, Stern L, Kott E, Huberman M (1994): Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients. Neurosci Lett 174:130-132.
113. Sheng JG, Mrak RE, Griffin WST (1994): S100β protein expression in Alzheimer disease: Potential role in the pathogenesis of neuritic plaques. J Neurosci Res 39:398-404.
114. Sheng JG, Mrak RE, Rovnaghi CR, Lozlowska E, Van Eldik LJ, Griffin WST (1996a): Human brain S100β and S100β mRNA expression increases with age: Pathogenic implications for Alzheimer's disease. Neurobiol Aging 17:359-363.
115. Sheng JG, Ito K, Skinner RD, Mrak RE, Rovnaghi CR, Van Eldik LJ, Griffin WST (1996b): In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol Aging 17:761-766.
116. Swedo S, Leonard H, Kiessling L (1994): Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood. Pediatrics 93:323-326.
117. -/- mice. J Immunol 159:1418-1428.
118. Taupin V, Renno T, Bourbonnière L, Peterson AC, Rodriguez M, Owens T (1997): Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-α in the central nervous system. Eur J Immunol 27:905-913.
119. Toulmond S, Vige X, Fage D, Benavides J (1992): Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci Lett 144:49-52.
120. Triozzi PL, Kinney P, Rinehart JJ (1990): Central nervous system toxicity of biological response modifiers. Ann NY Acad Sci 594:347-354.
121. Wang X, Yue TL, Barone FC, Feuerstein GZ (1995a): Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex. Stroke 26:661-666.
122. Wang X, Yue TL, White RF, Barone FC, Feuerstein GZ (1995b): Transforming growth factor-β1 exhibits delayed gene expression following focal cerebral ischemia. Brain Res Bull 36:607-609.
123. Wang X, Barone FC, Aiyar NV, Feuerstein GZ (1997): Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. Stroke 28:155-162.
124. Whicher JT, Evans SW (1990): Cytokines in disease. Clin Chem 36:1269-1281.
125. Wong ML, Gold PW, Licinio J (1993): In situ hybridization techniques for localization of interleukin 1 and interleukin 1 receptor antagonist mRNA in brain. Methods Neurosci 16:81-99.
126. Wood PL (1995): Microglia as a unique cellular target in the treatment of stroke: Potential neurotoxic mediators produced by activated microglia. Neurol Res 17:242-248.
127. Woodroofe C, Mueller W, Ruether U (1992): Long-term consequences of interleukin-6 overexpression in transgenic mice. DNA Cell Biol 11:587-592.
128. Wyss-Coray T, Feng L, Masliah E, Ruppe MD, Lee HS, Toggas SM, Rockenstein EM, Mucke L (1995): Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1. Am J Pathol 147:53-67.
129. Xia W, Zheng J, Perez R, Koo EH, Selkoe DJ (1997): Interaction between amyloid precursor protein and presenilins in mammalian cells: Implications for the pathogenesis of Alzheimer disease. Proc Natl Acad Sci USA 94:8208-8213.